Recce Pharmaceuticals Ltd (ASX:RCE)
Australia
· Delayed Price · Currency is AUD 0.460
-0.020 (-4.17%)
At close: Mar 6, 2026
Recce Pharmaceuticals Revenue
Recce Pharmaceuticals had revenue of 412.04K AUD in the half year ending December 31, 2025, a decrease of -82.70%. This brings the company's revenue in the last twelve months to 974.56K, down -89.84% year-over-year. In the fiscal year ending June 30, 2025, Recce Pharmaceuticals had annual revenue of 7.51M with 49.33% growth.
Revenue (ttm)
974.56K
Revenue Growth
-89.84%
P/S Ratio
136.50
Revenue / Employee
n/a
Employees
n/a
Market Cap
133.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 7.51M | 2.48M | 49.33% |
| Jun 30, 2024 | 5.03M | 663.14K | 15.19% |
| Jun 30, 2023 | 4.37M | 1.28M | 41.50% |
| Jun 30, 2022 | 3.08M | 1.45M | 88.41% |
| Jun 30, 2021 | 1.64M | 515.66K | 45.97% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Island Pharmaceuticals | 62.85K |
| Botanix Pharmaceuticals | 21.92M |
| Actinogen Medical | 7.36M |
| Paradigm Biopharmaceuticals | 8.45K |
| Starpharma Holdings | 14.58M |
| Arovella Therapeutics | 3.21M |
| Tetratherix | 2.00M |
| Cynata Therapeutics | 1.69M |